Objectives: Walking impairments are common in individuals with multiple sclerosis.
& Bostrom, 2009) and may increase cognitive attention toward walking (Wajda & Sosnoff, 2015) .
Only a few studies examined the effects of core stability interventions on walking in individuals with MS. Three randomized controlled trials (RCTs) compared Pilates exercises and standardized physical therapy (Expanded Disability Status Scale [EDSS] < 7). Two of them demonstrated significant within-group improvements in walking; however, no between-group differences were observed (Duff et al., 2018; Kalron, Rosenblum, Frid, & Achiron, 2017) . The third RCT observed differences between standardized exercises and relaxation; however, no differences were observed between Pilates and the mentioned interventions (Fox, Hough, Creanor, Gear, & Freeman, 2016) . A controlled trial (EDSS 0-4) comparing Pilates with home-based exercises indicated significant within-group effects on walking (Guclu-Gunduz, Citaker, Irkec, Nazliel, & Batur-Caglayan, 2014) , and two smaller studies (EDSS 3-6.5) demonstrated short-term improvements in walking parameters after Pilates (Freeman et al., 2010; Freeman & Allison, 2004) . In contrast to the current study, none of these studies demonstrated between-group differences, described a physical therapy examination, or presented how the individualization of the exercises was conducted. In the above-mentioned studies, Pilates exercises were considered the voluntary activation of deep abdominal muscles (Fox et al., 2016) . Traditionally, Pilates also includes cognitive attention, posture control, movement, precision, flow during transition, and coordinated breathing (Wells, Kolt, & Bialocerkowski, 2012) . Only one study presented group training, only two included participants with low EDSS scores (1-2.5), and in all studies, the follow-up periods were absent or short. In general, exercise therapy is associated with improvements in walking; however, no interventions have been shown to be more effective than others in individuals with MS (Hogan & Coote, 2013; Snook & Motl, 2009) , and some have demonstrated limited valuable impacts (Motl et al., 2017) .
Studies investigating walking using a long-term follow-up are called for (Snook & Motl, 2009 ), as are group-based interventions, because group settings are considered economically efficient (Humphreys, Drummond, Phillips, & Lincoln, 2013) . Studies examining individualized interventions interlinking core stability, dual tasks, and somatosensory retraining have been recommended (Fox et al., 2016; Gunn, Markevics, Haas, Marsden, & Freeman, 2015) .
A new group-based, individualized, comprehensive, core stability, and balance intervention called GroupCoreDIST (D = dual task, dose; S = somatosensory, stability, selective movement; I = individualized, insights; T = training, teaching) has been developed (Normann, Zanaboni, Arntzen, & Øberg, 2016) . The feasibility of GroupCoreDIST was demonstrated in a qualitative observation study (Dybesland & Normann, 2018 ) and a feasibility pilot study that showed significant within-group effects on balance and walking in 12 individuals with MS (EDSS 1-6.5; Normann, Salvesen, & Arntzen, 2016 ). In the current study, GroupCoreDIST was compared with standard care in an RCT.
The results from the two primary and one secondary outcomes regarding trunk control and balance have already been published, demonstrating short-and long-term significant between-group effects on the Trunk Impairment Scale-Norwegian Version and the Mini Balance Evaulation Systems Test (Mini-BESTest) (p < .05; both primary outcomes) and the Patient Global Impression of Change-balance (p < .05; secondary outcome; Arntzen et al., 2019) . The current paper present reports on the secondary outcomes on walking and addresses the following research question: What are the immediate and long-term effects of GroupCoreDIST compared with standard care on walking in individuals with MS? 2 | METHODS
| Design
This two-armed, prospective, single-blinded RCT included 80 ambulant individuals with MS. The study protocol was registered at ClinicalTrials. gov, and the protocol article has been previously published elsewhere (Normann, Zanaboni, et al., 2016) . This study was approved by the
Regional Committees for Medical and Health Research Ethics in
Norway and complied with the Declaration of Helsinki.
| Subjects and study setting
In August 2015, letters of invitation with a consent form were sent by the MS nurse at the Department of Neurology, Nordland Hospital Trust, Bodø, Norway, to 160 individuals with MS who were registered at the MS outpatient clinic and lived in one of the six municipalities included in the study. These municipalities were selected because they were located in both rural and urban areas (1,200-51,000 inhabitants) and had neurological physical therapists who were interested in learning GroupCoreDIST. A reminder letter was subsequently sent to ensure maximum patient enrolment. Ninety-three individuals replied with a signed consent form. Of the 67 individuals who did not respond, 57% had EDSS values ranging from 0 to 3.5, 21% had EDSS values ranging from 4 to 7, and 22% had unknown EDSS values. Enrolment was initiated in September 2015, and the follow-up assessments were completed in September 2016.
At enrolment, all participants underwent a clinical examination by a neurologist (F. O.) to assess their EDSS and medical history, including the type of MS, age, gender, weight, height, and medications. The inclusion criteria were as follows: (a) a diagnosis of MS in accordance with the McDonald criteria (Polman et al., 2011) ; (b) registered at the MS outpatient clinic; (c) living in one of the six selected municipalities; (d) aged 18 years or older; (e) capable of providing signed written informed consent; and (f) an EDSS value between 1 and 6.5 (1 = minor disability and 6.5 = able to walk 20 m with or without a walking aid). The exclusion criteria were as follows: (a) pregnancy at the time of examination; (b) exacerbation within 2 weeks prior to enrolment; and (c) other acute conditions resulting in compromised balance (such as acute neurological conditions, including stroke). Of the 93 individuals who consented to participate, 13 individuals were excluded, as follows: Two individuals did not attend the baseline assessment, five individuals could not commit the time, three individuals had an EDSS value of 0, one individual was pregnant, one individual was waiting for heart surgery, and one individual had moved from the catchment area.
| Randomization
The remaining 80 individuals completed the baseline testing and were randomly allocated to the GroupCoreDIST or standard care group by electronic concealed randomization using a web-based system developed and administered by the Unit of Applied Clinical Research, Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway (www.
webcrf.medisin.ntnu.no). The system was stratified on the basis of EDSS values of 1-3.5 and 4-6.5 to ensure a mix of individuals with high and low EDSS values in both groups. The group sessions were conducted in groups of three and were led by the physical therapist for 60 min, three times per week for 6 weeks. GroupCoreDIST contains 33 exercises, and each exercise has five optional variations to allow for individualization as the group members concurrently conduct the same exercise (although at different levels of difficulty). All exercises were performed barefoot and addressed dynamic core stability defined as the coordinated activation of local and global muscles of the trunk, pelvis, and shoulder girdle and the muscles attached to these areas (Kibler, Press, & Sciascia, 2006) . These areas provide the coordination and stability required for selective movement in proximal body regions and the potential for selective movement in the upper and lower limbs (Kibler et al., 2006) . The physical therapist chose the appropriate exercises and variations according to the participants' symptoms. All exercises addressed core muscle activation; however, the focus in the exercises was on the task, in order to use less cognitive attention directed toward the core. For instance, the participants were instructed to "keep your back in contact with the therapy ball and roll the ball from side to side." The potential for improved core muscle activation was also obtained indirectly during optimal alignment and adjustment to the base of support. These are aspects that differ the GroupCoreDIST from for instance, Pilates and general exercises. The exercises were divided into the following six categories, which were represented in each group session: were performed in all exercises as the activation of the core muscles was coordinated with other motor tasks. The motor-cognitive dual tasks included singing, rhyming, or calculating while performing exercises with the additional goal of promoting group dynamics and engagement. Verbal instructions and hands-on facilitation were allowed to improve the movement quality, decrease inexpedient compensatory movement patterns, and optimize the movement experience (Normann, 2018; Vaughan-Graham & Cott, 2016) . The protocol article provides details and further examples of the exercises (Normann, Zanaboni, et al., 2016) . All group members received a booklet with illustrations of the exercises, and the physical therapist prescribed unsupervised home-based exercises to be conducted twice per week for 30 min. The participants were encouraged to continue performing the home-based exercises after the intervention was completed for 30 min twice per week; however, these exercises were voluntary and unsupervised. The participants in GroupCoreDIST were encouraged to not seek other physical therapy during the 6-week intervention.
| Preparation, procedures, and interventions
The control group continued their regular routines, and the participants were encouraged to maintain their current level of physical activity. The participants were informed that they could see a physical therapist and seek any health care as required. Physical therapy was free to individuals with MS in Norway (at the time the study was conducted) and offered by both generalists and specialists; most often, physical therapy is received in a private practice or community-based service. The self-reports from the standard care group showed that 30 individuals (75%) did not visit a physical therapist within the 6 weeks GroupCoreDIST groups were encouraged to continue their usual medical treatment.
| Outcome measurements and procedure
The assessments were conducted at baseline, after the intervention was completed (Week 7; primary end-point), and at Weeks 18 and 30. Walking aids were allowed, and the participants were encouraged to use the same walking aid and shoes during all assessments. Two assessors who were blinded to the group allocation and adequately trained in the standardized test procedures conducted the assessments.
The outcome measures of walking included the 2-min walk test (2MWT), 10-m walk test (10MWT), Multiple Sclerosis Walking Scale-12 (MSWS-12), Patient Global Impression of Change-walking (PGICwalking), the Rivermead Visual Gait Assessment (RVGA), and ActiGraphsWgt3X-BT monitors (ActiGraph). The 2MWT measures walking distance, has good reliability and validity (Rossier & Wade, 2001) , and is recommended for intervention studies (Gijbels et al., 2012) . The participants were instructed to walk as far as they could in a 22-m-long hallway and turn at the end of the hall for a period of 2 min. The 10MWT measures walking speed and was conducted with a standing start at (a) the preferred speed, (b) slow speed, and (c) fast speed. The assessment has good reliability and validity among individuals with MS (Paltamaa, West, Sarasoja, Wikstrom, & Malkia, 2005; Rossier & Wade, 2001) .
The MSWS-12 captures how participants perceive their limitations while walking as a result of MS over the previous 2 weeks. Each of the 12 items is scored from 1 to 5 (lowest score 12 = no limitation). The MSWS-12 has good reliability and validity among individuals with MS (Hobart, Riazi, Lamping, Fitzpatrick, & Thompson, 2003; Kieseier & Pozzilli, 2012) . The total score was transformed into a 0-100 scale as recommended (Baert et al., 2014) . The PGIC-walking is scored on a 7-point Likert scale and measures how the participants perceive changes in walking (1 = very much worse, 4 = no change, and 7 = very much improved) compared with walking before the 6 weeks of GroupCoreDIST or standard care (Farrar, Young, LaMoreaux, Werth, & Poole, 2001) .
RVGA is a reliable and valid quantitative measure of an individual's gait quality (Lord, Halligan, & Wade, 1998) . RVGA describes how the gait pattern varies from normal and is measured on a 4-point scale (0 = normal and 4 = great abnormality) with a total score ranging from 0 to 59 when conducting two observations of the arms and 18 observations of the trunk and lower extremities (Lord et al., 1998) . The participants were videotaped while walking and scored on the basis of the film.
The ActiGraph is an activity monitor that registers information regarding the participants' activity level: number of steps and duration of intensity in activity (divided into different intensity levels: inactive, low, moderate, and vigorous; Block et al., 2016) . The monitor was worn in a belt around the participants' waist for 7 days after each assessment time point. The ActiGraph has been found to be an objective measure of community ambulation and physical activity in individuals with MS (Weikert, Motl, Suh, McAuley, & Wynn, 2010) .
General physical activity, the number of physical therapy treatments, perturbations, changes in medications and general well-being were recorded for both groups during the 6 weeks of GroupCoreDIST or standard care, and the number of home exercise sessions was additionally obtained for the GroupCoreDIST group.
| Sample size
The sample size calculation was based on assumptions of change in the Mini-BESTest, where a 0.75 standard deviation (SD) between the intervention group and the control group was considered relevant.
The results of the Mini-BESTest are presented in another manuscript . To achieve an 80% chance of detecting a 0.75 SD difference between the groups at a significance level of .05 (α), 28 individuals with MS were required per group. Anticipating a 30% dropout rate, we aimed to recruit at least 72 participants.
| Statistical analysis
Descriptive statistics (frequency, descriptive, and explore) were used to describe the demographic and clinical variables. The between-group differences over time were calculated using repeated-measures mixed models in IBM SPSS Version 24. The mixed-model approach has an advantage in addressing missing values and provides many options for adjusting for the dependence between repeated measures. An intention-to-treat analysis was performed for all participants with postassessment scores; however, some participants had missing observations. In the repeated-measures mixed-model analyses, the data structure involved four repeated measurements coded as a numeric time variable, and each follow-up time point was used as a reference. We adjusted for baseline by maintaining the baseline variable as a covariate in the model as recommended in the litterature (Twisk, 2013; Vickers & Altman, 2001 ). The final model of all outcomes included all independent variables that reached significance at p = .05 in any model. Group, time point, EDSS, gender, type of MS, age, and an interaction term composed of the time and group variables were included in the model. Other interaction terms with the intervention indicator were evaluated; however, these interaction terms did not reach significance and, thus, were not included. The estimated marginal means were used to create plots illustrating the effects of the intervention over time.
| RESULTS
The 80 participants were randomly allocated to the GroupCoreDIST (n = 40) or the standard care (n = 40) group after the baseline testing (Figure 3 ) demonstrated an overall significant difference by group (p = .016) and significant between-group effects at 7 (p = .011) and 18 weeks (p = .04). No significant differences were identified in the 10MWT-slow or 10MWTpreferred speeds or activity (neither number of steps nor activity level) at any time point. The RVGA demonstrated a significant betweengroup difference at 7 weeks (p = .03).
The MSWS-12 100scale (Figure 4) demonstrated an overall significant difference by group (p = .011) and significant between-group differences at 7 (p = .004) and 18 weeks (p = .019). The PGIC-walking ( Figure 5 ) demonstrated an overall significant difference by group (p < .00) and significant between-group differences at all time points (p < .00).
| DISCUSSION
This assessor-blinded prospective RCT evaluated the short-and long-term effects of a 6-week GroupCoreDIST intervention compared with standard care. The results demonstrated significant betweengroup effects in favour of GroupCoreDIST on walking distance and self-perceived change in walking that lasted for 24 weeks, on fast walking speed and self-perceived walking mobility that lasted for 12 weeks, and on gait quality immediately after the intervention was completed.
| Strengths and weaknesses compared with those of other studies
Several studies have shown that core control is important for balance (Aruin, Kanekar, & Lee, 2015; Borghuis, Hof, & Lemmink, 2008; Kibler et al., 2006) . However, knowledge regarding whether comprehensive core stability and balance training impact walking is limited. In the current study, the participants were mildly impaired given their low EDSS scores (average 2.36). Despite the low overall disability indicated by the EDSS, the participants had substantial walking limitations FIGURE 1 Flowchart of the recruitment, allocation and retention of participants throughout the study. MS, multiple sclerosis considering their average walking distance at baseline (167.87 m in the 2MWT), which was significantly shorter than the previously published average distance in healthy individuals (211 m; 95% CI [191, 234 m]; Selman, de Camargo, Santos, Lanza, & Dal Corso, 2014) . This finding suggests the need for early rehabilitation in mildly impaired individuals to improve walking, which is also indicated in other studies (Langeskov-Christensen et al., 2017) . A clinically meaningful change in the 2MWT was defined as an improvement of 9.6 and 6.8 m from the patient and clinician perspectives, respectively, in one study (Baert et al., 2014 ) and a 12% improvement in another study (Learmonth, Dlugonski, Pilutti, Sandroff, & Motl, 2013) . Our results demonstrated a clinically meaningful change in the GroupCoreDIST group at all assessment points as follows: 18-m (11%) improvement at 7 weeks, 20-m (12%) improvement at 18 weeks, and 18-m (11%) improvement at 30 weeks. The 10MWT-fast speed also showed significant effects at 7 and 18 weeks. However, walking at the preferred or a slow speed did not improve, which may be related to the psychometrics of the test as walking at the preferred speed exhibited more within-day variability than walking at a fast speed . The 10MWTfast speed is more comparable with long walking tests than walking at the preferred speed, and the 2MWT is more comparable with habitual walking behaviour than the 10MWT (Gijbels et al., 2010) .
In contrast to the clinical walking outcomes, the activity monitors (ActiGraph) detected no effects, which is not surprising because the Note. The results show the means and SD of the GroupCoreDIST and standard care groups at all time points, and the means, 95% confidence intervals (CI), standard error (SE), and p values of the between-group differences at the 7-, 18-, and 30-week assessments. Significant between-group differences at 7, 18, and 30 weeks and overall differences are indicated. GroupCoreDIST did not emphasize activity or encourage the participants to increase their activity level. Compared with healthy individuals in Norway, our participants had lower activity levels (Hansen et al., 2019) ; however, compared with individuals with MS, participants in both groups had higher amount of steps per day than reported in a prior study (Learmonth & Motl, 2016) . This may be explained due to the high amount of individuals with EDSS 1-2 in our study and the wide standard deviations in both groups, implying a great variation regarding activity.
The MSWS-12 demonstrated significant effects at 7 and 18 weeks.
There is no clear agreement regarding the definition of a standard clinically meaningful change in the MSWS-12; however, values between −6 and −11 points have been suggested previously (Baert et al., 2014; Baert et al., 2018; Hobart et al., 2003; Mehta et al., 2015) .
The current study demonstrated a −7-point improvement in the GroupCoreDIST group from baseline to 7 weeks, indicating a clinically meaningful improvement. The MSWS-12 is associated with changes in walking distance and speed , which were observed in this RCT. The MSWS-12 has also been suggested to particularly capture changes in individuals within the low EDSS range (Langeskov-Christensen et al., 2017) , which was the case for most participants. The MSWS-12 and the PGIC-walking reflect improvements in assessed walking distance and speed. The RVGA demonstrated that the participants had few abnormalities in the quality of walking or at least abnormalities that were captured by this outcome measurement.
The low baseline scores in both groups may indicate a borderline floor effect and, thereby, limited the possibilities for improvement in the RVGA because the creators of this outcome measurement indicated that an 11-point change is a significant change in gait quality (Lord et al., 1998) .
The results from this study contradict the view that gait training is required for improving walking (Lederman, 2010) because
GroupCoreDIST does not include walking. Other studies assessing walking after Pilates, resistance training, or general exercises have demonstrated effects on walking speed (Freeman et al., 2010; Kalron et al., 2017; Kjølhede, Vissing, & Dalgas, 2012; Pearson, Dieberg, & Smart, 2015) or distance (Freeman & Allison, 2004; Gunn et al., 2015; Kalron et al., 2017; Kjølhede et al., 2012; Pearson et al., 2015) ; however, some studies have shown no effect on walking (Fox et al., 2016; Kjølhede et al., 2012) . The current study is distinguished by the finding that the walking distance, speed, quality, and self-perceived outcome measures of walking all improved, which may indicate that exercises that comprehensively address aspects of core stability and the prerequisites of optimal balance control influence walking.
| Explanation of findings
GroupCoreDIST highlights trunk muscle activation in coordination with activity in the limbs and other underlying aspects of balance, such as somatosensory activation of the feet, adaptation to the base of support, muscle length, and larger muscle groups. The improvements in walking may be related to the high dose of trunk muscle activation, which is imperative for monitoring displacements and optimizing steps while walking (Huisinga et al., 2014) . Moreover, the intervention addresses malalignment of the trunk, hip, ankle, and foot, which are all important elements for adequate ankle and hip strategies and the ability to make longer steps, which may explain the faster walking speed (Gjelsvik & Syre, 2016; Shumway-Cook & Woollacott, 2017) . Optimal somatosensory information, alignment, and dynamic adaptation to the base of support were addressed in the exercises because individuals with MSinduced mild to moderate disability tend to have decreased sensation in their feet (Citaker et al., 2011) . Although these aspects are essential for walking (Arpin, Gehringer, Wilson, & Kurz, 2017) with a few months in between and also the need to explore other elements to support adherence.
| Strengths and limitations of the trial
The group trainings were highly attended, which may have been the result of motivation and group dynamics as social settings are often motivating and may lead to increased general physical activities (Dodd, Taylor, Denisenko, & Prasad, 2006) . However, the self-scorings indicated equal activity levels in both groups throughout the 6 weeks.
Moreover, the well-being similar scores in the two groups imply that the social aspects of the intervention were unlikely to have caused the improvements in walking. The lacking changes in activity may also underscore that the effects on walking that occurred as a result of the intervention and not due to increased activity level. One methodological consideration is that the groups were not matched for volume of physical therapy, which implies less attention and lower expectations for improvement in the standard care group. However, standard care is a common comparator in RCTs, and the content is well described (Zwarenstein, Treweek, & Loudon, 2017 This RCT included a physical therapy examination as the basis for individualization, which is important given that individuals with MS have various impairments (Cameron & Lord, 2010) . Individualization may limit and create imprecision in an RCT because controlling for the specific contents of the intervention may be compromised; however, the physical therapists were adequately trained in the intervention, followed a detailed manual, and registered the exercises used (Zwarenstein et al., 2008) . No injuries related to the intervention were reported, and only one individual reported an exacerbation (sensory), indicating that GroupCoreDIST was well tolerated. Ambulant individuals with all types of MS and varied EDSS scores (1-6.5) participated;
however, as a group, their EDSS level was quite low (mean 2.36). This finding demonstrates walking impairments in individuals with low EDSS as previously described in other studies (Sosnoff et al., 2012) and displays the potential for improvements in this group. Among all participants, 81% had an EDSS score of 1-3.5, which could indicate recruitment bias and, thus, limit generalizability. Among those who did not respond to the invitation to participate in the study, 57% had an EDSS score of 0-3.5, and 22% had an unknown EDSS score, indicating that the sample in this study is fairly similar to the MS population in the MS outpatient clinic. We consider the outpatient clinic to be no different from others in Norway, indicating that there was no recruitment bias; however, other countries may have given a different sample.
Multiplicity of analyses may be a limitation because we used many outcome measures to explore walking. However, exploring different aspects of walking is important because GroupCoreDIST is a new intervention. Additionally, physical therapists from six municipalities participated, rendering the external validity high and the results transferable to other similar populations and settings (Zwarenstein et al., 2017) .
| IMPLICATIONS FOR PHYSICAL THERAPY PRACTICE
The immediate and long-term effects on walking demonstrated in this study support the initiation of GroupCoreDIST in ambulant individuals with MS (EDSS values 1-6.5). The usefulness of this approach among people with more severe MS ought to be investigated further. The prevailing principle of individualization in neurological physical therapy (Rehabilitation in Multiple Sclerosis (RIMS), 2012, April) has previously been questioned in group settings (Kalron et al., 2019; Plow, Mathiowetz, & Lowe, 2009 ). In our studies, comprehensive and individualized core stability and balance exercises were demonstrated to be feasible (Normann, Salvesen, & Arntzen, 2016) and effective regarding balance and walking when performed in small groups. Individualization may therefore be an important element to implement in group-based physical therapy. The high dose and intensity of the GroupCoreDIST seemed important for the improvements in walking, and the fact that the standard care followup in our area foremost contained low dose and general activities may indicate that a more intensive and structured physical therapy treatment is needed for this population.
In conclusion, compared with standard care, 6 weeks of
GroupCoreDIST produced immediate and long-term significant and clinically meaningful effects on walking. The intervention represents an effective contribution to clinical practice. In future studies, GroupCoreDIST needs to be compared with other types of exercise programmes of equal dosage in order to establish any superiority and support the theoretical underpinnings.
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